Oral options are now becoming more important, including oral semaglutide formulations and orforglipron, marketed as Foundayo
Fatime Cody Stanford, an obesity medicine physician at Mass General Brigham and associate professor at Harvard Medical School, warns that compounded versions of the drugs are not the same and they are not tested
They can help determine if Semaglutide or another factor is the cause
View CBS News In CBS News App Open Chrome Safari Continue
Whether youre dealing with nutrient deficiencies, managing a chronic condition, or simply looking to enhance your overall wellness, our experts can guide you in selecting the right supplements to meet your needs
For example, participants in the OASIS 1 trial experienced an average weight loss of 14.9%